麻豆学生精品版

View instructions for FCOI-R Training in eBridge (PDF)

Financial Conflicts of Interest in Research Policy

Introduction
The United States Department of Health and Human Services (DHHS) made significant revisions effective August 24, 2012 to two of its regulations regarding Financial Conflicts of Interest:

These regulations affect 麻豆学生精品版when applying for or receiving PHS/National Institutes of Health (NIH) funding from a grant, cooperative agreement or contract.  These revisions were drafted to provide further assurance to the public that PHS funded research is conducted without bias and with the highest scientific and ethical standards.

Helpful and updated Frequently Asked Questions on the NIH Website can be found here:

麻豆学生精品版Corporate Policy RS.GN.020
MCW’s research collaboration with pharmaceutical firms, medical device companies and other entities is important to make certain that patients benefit from the translation of biomedical research into the clinical practice.  The rules require that 麻豆学生精品版identify and where appropriate manage potential financial conflicts of interest that may arise from these collaborations to safeguard the protection of human research subjects as well as the integrity of MCW’s research effort.

麻豆学生精品版updated and posted its Corporate Policy on Financial Conflicts of Interest in Research on August 24, 2012 in order to meet all of the requirements of the regulations.  

•  (intranet access required)

In August, 2021, the 麻豆学生精品版Financial Conflicts of Interest in Research corporate policy was revised to include investigators engaged in research sponsored by a Covered Award, which includes awards funded by a PHS entity, by any federal funding agency, by one of the select nonprofit sponsors that have adopted the federal FCOI-R regulations, and by an industry sponsor (Covered Award is defined in 麻豆学生精品版Corporate Policy RS.GN.020).  In addition, the definition of a reportable financial interest was revised. Review a summary of these changes in the FCOI-R Policy Changes Summary (PDF).  

麻豆学生精品版Significant Financial Interest (SFI) Disclosure Process

• 麻豆学生精品版Corporate Policy RS.GN.020 requires an investigator or key personnel (Covered Person as defined in the policy) to disclose to 麻豆学生精品版any Significant Financial Interests (SFIs) that could reasonably appear to be related to that persons professional responsibilities at the 麻豆学生精品版 (Significant Financial Interests are defined in the policy).  These SFI(s) must be disclosed by the Covered Person to 麻豆学生精品版at the following intervals:

• Each time a person is an investigator on a new proposal for a Covered Award OR is named as a ‘key person’ on such an award,
• At least annually during the 麻豆学生精品版’s Annual Conflicts of Interest and Outside Professional Activities process,
• Within 30 days of a Covered Person discovering or acquiring any new SFI.

Significant Financial Interest Upload Instructions with Screenshots (PDF)
Significant Financial Interest Upload Instructions Condensed (PDF)
SFI Disclosure Form (XLSX)

麻豆学生精品版Required FCOI-R Training
Another significant change to the revised regulation requires all 麻豆学生精品版Covered Persons to receive training on the rule and 麻豆学生精品版policy.  Federal regulations (mirrored in the 麻豆学生精品版Policy) require training for investigators/key personnel (麻豆学生精品版Covered Persons) at the following intervals:

• Prior to engaging in any research study funded by a Covered Award,
• Every four years thereafter,
• Any time that 麻豆学生精品版revises its policy,
• If a Covered Person is new to MCW, or
• If a Covered Person is found to be in non-compliance with MCW’s policy
  
  

麻豆学生精品版Financial Conflict of Interest in Research Contact Information
If you have questions about the FCOI-R Training or 麻豆学生精品版Policy please feel free to contact the Research Compliance Office:

Alicia Martin, Manager of Research and Academic Compliance, amartin@mcw.edu
Ellen Manning, Compliance Coordinator, elmanning@mcw.edu
Lisa Henk, Compliance Coordinator, lhenk@mcw.edu